Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q3 2024 Earnings

12AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.58

-0.53

-0.47

-0.42

Details

Expected EPS

-0.43

Actual EPS

-0.46

Surprise EPS

-0.03

Surprise Percent

+6.98%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.46 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.